Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
International Journal of Oncology
|
September 20, 2001
Human stomach-specific gene, CA11, is down-regulated in gastric cancer
K Shiozaki, S Nakamori, M Tsujie, et al.
Digestive Diseases and Sciences
|
September 18, 1999
Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging
J Shimizu, K Dono, M Gotoh, et al.
Transplantation
|
June 27, 2000
The inhibitory effect of prostaglandin E1 on oxidative stress-induced hepatocyte injury evaluated by calpain-mu activation
S Kishimoto, M Sakon, K Umeshita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 1999
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas
J Okami, H Yamamoto, Y Fujiwara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2000
Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma
M Kondo, H Yamamoto, H Nagano, et al.
Transplantation
|
January 28, 1999
Microchimerism in thymus is associated with up-regulated T helper type 1 cytokine transcription during cardiac allograft rejection in rats
H Ota, M Gotoh, H Ohzato, et al.
Oncogene
|
June 23, 2009
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma
H Akita, Z Zheng, Y Takeda, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1999
Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence
Y Ito, N Matsuura, M Sakon, et al.
British Journal of Cancer
|
March 29, 2000
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
Y Ito, M Monden, T Takeda, et al.
British Journal of Cancer
|
April 30, 2009
Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma
T Noda, H Nagano, I Takemasa, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
International Journal of Oncology
|
September 20, 2001
Human stomach-specific gene, CA11, is down-regulated in gastric cancer
K Shiozaki, S Nakamori, M Tsujie, et al.
Digestive Diseases and Sciences
|
September 18, 1999
Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging
J Shimizu, K Dono, M Gotoh, et al.
Transplantation
|
June 27, 2000
The inhibitory effect of prostaglandin E1 on oxidative stress-induced hepatocyte injury evaluated by calpain-mu activation
S Kishimoto, M Sakon, K Umeshita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 1999
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas
J Okami, H Yamamoto, Y Fujiwara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2000
Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma
M Kondo, H Yamamoto, H Nagano, et al.
Transplantation
|
January 28, 1999
Microchimerism in thymus is associated with up-regulated T helper type 1 cytokine transcription during cardiac allograft rejection in rats
H Ota, M Gotoh, H Ohzato, et al.
Oncogene
|
June 23, 2009
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma
H Akita, Z Zheng, Y Takeda, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1999
Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence
Y Ito, N Matsuura, M Sakon, et al.
British Journal of Cancer
|
March 29, 2000
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
Y Ito, M Monden, T Takeda, et al.
British Journal of Cancer
|
April 30, 2009
Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma
T Noda, H Nagano, I Takemasa, et al.
Page
of 8